Fidelity Investments’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152M | Buy |
4,855,772
+15,276
| +0.3% | +$479K | 0.01% | 936 |
|
|
2025
Q1 | $144M | Buy |
4,840,496
+22,797
| +0.5% | +$676K | 0.01% | 940 |
|
|
2024
Q4 | $142M | Sell |
4,817,699
-18,341
| -0.4% | -$541K | 0.01% | 970 |
|
|
2024
Q3 | $151M | Buy |
4,836,040
+23,436
| +0.5% | +$730K | 0.01% | 933 |
|
|
2024
Q2 | $163M | Buy |
4,812,604
+500,460
| +12% | +$17M | 0.01% | 854 |
|
|
2024
Q1 | $280M | Buy |
4,312,144
+2,615,758
| +154% | +$170M | 0.02% | 657 |
|
|
2023
Q4 | $116M | Sell |
1,696,386
-439,837
| -21% | -$30M | 0.01% | 956 |
|
|
2023
Q3 | $111M | Buy |
2,136,223
+90,116
| +4% | +$4.68M | 0.01% | 924 |
|
|
2023
Q2 | $123M | Sell |
2,046,107
-43,444
| -2% | -$2.6M | 0.01% | 906 |
|
|
2023
Q1 | $103M | Buy |
2,089,551
+85,638
| +4% | +$4.23M | 0.01% | 976 |
|
|
2022
Q4 | $114M | Buy |
2,003,913
+610,679
| +44% | +$34.9M | 0.01% | 921 |
|
|
2022
Q3 | $65.4M | Buy |
1,393,234
+32,850
| +2% | +$1.54M | 0.01% | 1133 |
|
|
2022
Q2 | $50.8M | Sell |
1,360,384
-267,171
| -16% | -$9.97M | 0.01% | 1254 |
|
|
2022
Q1 | $48.7M | Sell |
1,627,555
-495,772
| -23% | -$14.8M | ﹤0.01% | 1399 |
|
|
2021
Q4 | $72.7M | Sell |
2,123,327
-57,659
| -3% | -$1.97M | 0.01% | 1262 |
|
|
2021
Q3 | $80.8M | Buy |
2,180,986
+949,142
| +77% | +$35.2M | 0.01% | 1195 |
|
|
2021
Q2 | $48.1M | Sell |
1,231,844
-189,293
| -13% | -$7.39M | ﹤0.01% | 1453 |
|
|
2021
Q1 | $60.5M | Buy |
+1,421,137
| New | +$60.5M | 0.01% | 1305 |
|